Injection site discharge: Which Medications Cause It? (3,693 Reports Across 80 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Injection site discharge has been reported as an adverse event with 80 different drugs in the FDA's FAERS database, with 3,693 total reports. 18 of these reports resulted in death.The drugs most commonly associated with Injection site discharge are ADALIMUMAB, TREPROSTINIL, and SEMAGLUTIDE.
3,693
Total Reports
80
Drugs Involved
18
Deaths
342
Hospitalizations
46.3 yrs
Average Patient Age
67.5% / 32.5%
Female / Male
Which Drugs Cause Injection site discharge Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| ADALIMUMAB | 691 | 0.1% | 0 | 28 | 0 |
| TREPROSTINIL | 463 | 0.5% | 7 | 157 | 6 |
| SEMAGLUTIDE | 388 | 0.7% | 0 | 6 | 0 |
| SOMATROPIN | 283 | 0.4% | 0 | 3 | 0 |
| DUPILUMAB | 130 | 0.0% | 0 | 4 | 0 |
| FREMANEZUMAB-VFRM | 117 | 1.3% | 0 | 0 | 0 |
| EXENATIDE | 110 | 0.4% | 0 | 4 | 1 |
| RISANKIZUMAB-RZAA | 107 | 0.2% | 0 | 4 | 0 |
| CORTICOTROPIN | 98 | 0.8% | 0 | 4 | 0 |
| VEDOLIZUMAB | 87 | 0.1% | 0 | 6 | 0 |
| HUMAN IMMUNOGLOBULIN G | 85 | 0.1% | 2 | 27 | 0 |
| OFATUMUMAB | 75 | 0.3% | 0 | 0 | 1 |
| SECUKINUMAB | 62 | 0.0% | 0 | 1 | 0 |
| CABOTEGRAVIR | 57 | 0.7% | 0 | 1 | 0 |
| AMBRISENTAN | 54 | 0.1% | 3 | 23 | 0 |
| CABOTEGRAVIR\RILPIVIRINE | 54 | 1.1% | 0 | 1 | 0 |
| LEUPROLIDE | 52 | 0.1% | 0 | 0 | 0 |
| RILPIVIRINE | 50 | 0.7% | 0 | 1 | 0 |
| BUPRENORPHINE | 45 | 0.1% | 0 | 2 | 0 |
| LENACAPAVIR | 41 | 8.2% | 0 | 0 | 0 |